Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival

Neurology

Volumn 67, Issue 5, 2006, Pages 814-819

  Gosk Bierska, I ^a,b   Wysokinski, W ^a   Brown Jr , R D ^a   Karnicki, K ^a   Grill, D ^a   Wiste, H ^a   Wysokinska, E ^a,b   McBane II, R D ^a  

^a MAYO CLINIC   (United States)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECTUM CANCER; RECURRENT DISEASE; RISK FACTOR; SINUS VENOSUS; SURVIVAL RATE; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULANTS; CEREBRAL VEINS; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; INCIDENCE; LOWER EXTREMITY; MALE; MIDDLE AGED; RECURRENCE; REFERENCE VALUES; RETROSPECTIVE STUDIES; THROMBOPHILIA; VENOUS THROMBOSIS; WARFARIN;

EID: 33748691410     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000233887.17638.d0     Document Type: Article

References (13)

1. Stam J. Current concepts: thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791-1798.
2. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597-600.
3. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484-488.
4. Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002;4:CD002005-CD002005.
5. Bousser MG. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke 1999;30:481-483.
6. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) Stroke 2004;35:664-670.
7. Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients Stroke 1996;27:243-246.
8. de Bruijn SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 2001;70:105-108.
9. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J. Long-term prognosis of cerebral vein and dural sinus thrombosis. Results of the VENOPORT study. Cerebrovasc Dis 2002;13:272-278.
10. Breteau G, Mounier-Vehier F, Godefroy O, et al. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol 2003;250:29-35.
11. Cakmak S, Derex L, Berruyer M, et al. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology 2003;60:1175-1178.
12. Therneau T, Sicks J, Bergstralh E, Offord J. Expected survival based on hazard rates. Technical report series. No. 52. Section of biostatistics. Rochester, MN: Mayo Clinic, 1994.
13. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:483S-512S.